Dyne Therapeutics (DYN) Earnings Analysis

Dyne Therapeutics (DYN) next reports earnings on 2026-07-27, consensus EPS -0.74 USD. Last quarter (2026-05-11) it beat with EPS -0.73 USD vs -0.77229 USD est (+5.5%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -7.21.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DYN next report earnings?

Next earnings date2026-07-27
Consensus EPS estimate-0.74 USD
Revenue estimaten/a

DYN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.73 USD-0.77229 USD+5.5%Beat
2026-03-02-0.76 USD-0.74 USD-2.7%Miss
2025-07-28-0.97 USD-0.99 USD+2%Beat
2025-02-27-0.88 USD-0.92 USD+4.3%Beat
2024-08-12-0.7 USD-0.72 USD+2.8%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

DYN valuation and analyst view

Trailing P/E-7.21
Trailing EPS-2.73701 USD
Price / book4.43
Dividend yield0.00%
Market cap3.71B
Analyst consensusBuy (12 buy / 2 hold / 0 sell)
Avg price target28.5 USD

Related research pages

Frequently asked questions

When is Dyne Therapeutics (DYN)'s next earnings date?

Dyne Therapeutics is next scheduled to report on 2026-07-27, with a consensus EPS estimate of -0.74 USD.

Did DYN beat earnings last quarter?

In its 2026-05-11 report, DYN posted EPS of -0.73 USD versus a -0.77229 USD estimate — a beat of 5.5%.

What is DYN's earnings track record?

Over the last 5 reported quarters with consensus data, DYN beat estimates 4 times (80%).

What is DYN's current P/E ratio and EPS?

DYN trades at a trailing P/E of -7.21 on trailing EPS of -2.737010996663504 USD.

What do analysts rate DYN?

Analyst consensus is "Buy" across 14 ratings (1 strong buy, 11 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 28.5 USD.